A short article “Can we expect a pronounced effect of neprilysin inhibition by LCZ696 on the levels of immunoreactive BNP? ” written by Dr. Alexander Semenov, one of HyTest’s scientists, was published in NACB Scientific Shorts in October.
We are delighted to let you know that we are sponsoring the new IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics. The award honors an individual who has undertaken remarkable scientific work with cardiac markers or immunodiagnostic applications to improve cardiac disease diagnosis.
HyTest participates in Medica exhibition in November. If you or your colleagues will attend the MEDICA 2016 - the World's Leading Medical Forum - from November 14 to 17, in Düsseldorf, Germany, please schedule a meeting with us.
We provide five in vitro-produced monoclonal antibodies that are specific to human Lp-PLA2. They can be used for the development of quantitative immunoassays which enable the detection of Lp-PLA2 from plasma samples. In addition, we provide recombinant human Lp-PLA2.